<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02392195</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00004233</org_study_id>
    <nct_id>NCT02392195</nct_id>
  </id_info>
  <brief_title>Brain Characteristics Noted Prior to and Following Treatment</brief_title>
  <official_title>Brain Characteristics Noted Prior to and Following Treatment of Deformational Plagiocephaly With a Helmet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will enable investigators to find out if brain structure and characteristics are&#xD;
      affected by the shape of the infant's head, and if changes in the brain occur with helmet&#xD;
      therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A dramatic increase in the number of infants diagnosed with Deformational Plagiocephaly (DP)&#xD;
      has been observed worldwide since institution of the American Academy of Pediatrics' Back to&#xD;
      Sleep Program. According to one published report, the incidence of DP ranges between 3-48%;&#xD;
      this translates into120,000-2 million infants/year who develop DP in the United States alone.&#xD;
      Some healthcare providers believe that DP is a purely cosmetic condition. This mindset&#xD;
      undermines the importance of prevention and correction. In New Zealand, a recent study&#xD;
      demonstrated that 39% of children without corrective action had persistent DP at age 3 to 4&#xD;
      years. Additionally, several studies have demonstrated associations between impaired social&#xD;
      interactions, developmental problems and DP.Thus some researchers now believe that there may&#xD;
      be a spectrum of untoward outcomes from brain remodeling resulting from DP. Recent&#xD;
      technological advances now allow the detection of diminutive changes in brain structure. In&#xD;
      this multidisciplinary descriptive pilot study we will use brain MRI (Magnetic Resonance&#xD;
      Imaging) and a cerebral tissue oxygenation monitor, namely Frequency Domain Near Infrared and&#xD;
      Diffuse Correlation Spectroscopy (FDNIR/DCS) to describe if differences in brain structure&#xD;
      and characteristics exist in infants with significant DP before and after correction of the&#xD;
      deformational defect. This study will enable investigators to seek preliminary evidence that&#xD;
      brain development is influenced by the shape of the cranial vault, and that changes in brain&#xD;
      structure and characteristics occur with helmet therapy. Additionally this study will help to&#xD;
      determine the need for a larger investigation of this phenomenon that would further establish&#xD;
      an association between DP and developmental delay.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2013</start_date>
  <completion_date type="Actual">September 2020</completion_date>
  <primary_completion_date type="Actual">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Qualitatively Determined Normalization of White Matter Pathways</measure>
    <time_frame>2-6 months</time_frame>
    <description>We will compare if nerve pathways are appreciably different in the area of head flattening following helmet therapy by visual examination and comparison of areas of asymmetry vs. symmetry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Improved Developmental Exams Post Helmet Therapy</measure>
    <time_frame>2-6 months</time_frame>
    <description>The Mullen (Scales of Early Learning) was used to determine developmental scores. This tool provides a profile of cognitive ability in five areas:&#xD;
Gross Motor, Fine Motor, Expressive Language, Receptive Language, and Visual Reception. Each of the 5 assessment that has a raw score that is then given a percentile rank and descriptive category (below average, average, above average) for interpretation purposes. Descriptive categories pre treatment were compared to post treatment to determine if scores had improved.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants With Improved Cranial Asymmetry After Cranial Orthotic Treatment</measure>
    <time_frame>Collected retrospectively</time_frame>
    <description>Cranial asymmetry was assessed using the Cranial Vault Asymmetry Index (CVAI). MRI's were utilized to determine CVAI. Asymmetry pre treatment was compared to post treatment to see if asymmetry improved.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">10</enrollment>
  <condition>Nonsynostotic Plagiocephaly</condition>
  <arm_group>
    <arm_group_label>Single arm; Non-interventional</arm_group_label>
    <description>A convenience sample of 10-15 infants born at term gestation, that are &lt;/= 6 months of age with significant DP (defined as head flattening requiring helmet therapy) and no major health issues will be recruited into this phase 1 descriptive pilot study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-interventional</intervention_name>
    <description>Observational</description>
    <arm_group_label>Single arm; Non-interventional</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Deformational Plagiocephaly in full term, healthy infants.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. - DP requiring helmet therapy&#xD;
&#xD;
          2. -Term gestation at birth (37 weeks or greater)&#xD;
&#xD;
          3. -Less than/or equal to 8 months of age&#xD;
&#xD;
          4. -No history of major health problem such as birth injury, genetic disorder,&#xD;
             intracranial hemorrhage, hydrocephalus, neurologic abnormality&#xD;
&#xD;
          5. -No history of implantable metal device or internal/external orthotic device&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. - DP not requiring helmet therapy&#xD;
&#xD;
          2. -Premature gestation at birth (less than 37 weeks gestation).&#xD;
&#xD;
          3. -Greater than 8 months of age&#xD;
&#xD;
          4. -History of major health problem such as birth injury genetic disorder, intracranial&#xD;
             hemorrhage, hydrocephalus, neurologic abnormality&#xD;
&#xD;
          5. -History of implantable metal device or internal/external orthotic device&#xD;
&#xD;
          6. -Infants not completing prescribed treatment for correction with a helmet&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michele DeGrazia, PhD, RN, NNP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>March 12, 2015</study_first_submitted>
  <study_first_submitted_qc>March 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2015</study_first_posted>
  <results_first_submitted>September 23, 2020</results_first_submitted>
  <results_first_submitted_qc>December 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 10, 2020</results_first_posted>
  <last_update_submitted>December 9, 2020</last_update_submitted>
  <last_update_submitted_qc>December 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Michele DeGrazia</investigator_full_name>
    <investigator_title>Director Nursing Research NICU</investigator_title>
  </responsible_party>
  <keyword>Plagiocephaly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plagiocephaly</mesh_term>
    <mesh_term>Plagiocephaly, Nonsynostotic</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 29, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/95/NCT02392195/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Single Arm; Non-interventional</title>
          <description>A convenience sample of 10-15 infants born at term gestation, that are &lt;/= 6 months of age with significant DP (defined as head flattening requiring helmet therapy) and no major health issues will be recruited into this phase 1 descriptive pilot study&#xD;
Non-interventional: Observational</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single Arm; Non-interventional</title>
          <description>A convenience sample of infants born at term gestation, &lt;/= 6 months of age with significant Deformational Plagiocephaly (DP) (defined as head flattening requiring helmet therapy) and no major health issues will be recruited into this phase 1 descriptive pilot study&#xD;
Non-interventional: Observational</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6" lower_limit="5" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cranial vault asymmetry index (CVAI) &gt; 8.75%</title>
          <description>Cranial vault asymmetry (CVA): the absolute difference in cranial diagonals.&#xD;
Cranial vault asymmetry (CVAI): measure of cranial vault asymmetry in relationship to the overall size of the head, it is the difference between the diagonals divided by the longer of the diagonals multiplied by 100.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Qualitatively Determined Normalization of White Matter Pathways</title>
        <description>We will compare if nerve pathways are appreciably different in the area of head flattening following helmet therapy by visual examination and comparison of areas of asymmetry vs. symmetry.</description>
        <time_frame>2-6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single Arm; Non-interventional</title>
            <description>A convenience sample of infants born at term gestation, that are &lt;/= 6 months of age with significant DP (defined as head flattening requiring helmet therapy) and no major health issues will be recruited into this phase 1 descriptive pilot study&#xD;
Non-interventional: Observational</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Qualitatively Determined Normalization of White Matter Pathways</title>
          <description>We will compare if nerve pathways are appreciably different in the area of head flattening following helmet therapy by visual examination and comparison of areas of asymmetry vs. symmetry.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Improved Developmental Exams Post Helmet Therapy</title>
        <description>The Mullen (Scales of Early Learning) was used to determine developmental scores. This tool provides a profile of cognitive ability in five areas:&#xD;
Gross Motor, Fine Motor, Expressive Language, Receptive Language, and Visual Reception. Each of the 5 assessment that has a raw score that is then given a percentile rank and descriptive category (below average, average, above average) for interpretation purposes. Descriptive categories pre treatment were compared to post treatment to determine if scores had improved.</description>
        <time_frame>2-6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single Arm; Non-interventional</title>
            <description>A convenience sample of infants born at term gestation, that are &lt;/= 6 months of age with significant DP (defined as head flattening requiring helmet therapy) and no major health issues will be recruited into this phase 1 descriptive pilot study&#xD;
Non-interventional: Observational</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Improved Developmental Exams Post Helmet Therapy</title>
          <description>The Mullen (Scales of Early Learning) was used to determine developmental scores. This tool provides a profile of cognitive ability in five areas:&#xD;
Gross Motor, Fine Motor, Expressive Language, Receptive Language, and Visual Reception. Each of the 5 assessment that has a raw score that is then given a percentile rank and descriptive category (below average, average, above average) for interpretation purposes. Descriptive categories pre treatment were compared to post treatment to determine if scores had improved.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Improved Cranial Asymmetry After Cranial Orthotic Treatment</title>
        <description>Cranial asymmetry was assessed using the Cranial Vault Asymmetry Index (CVAI). MRI's were utilized to determine CVAI. Asymmetry pre treatment was compared to post treatment to see if asymmetry improved.</description>
        <time_frame>Collected retrospectively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single Arm; Non-interventional</title>
            <description>A convenience sample of infants born at term gestation, that are &lt;/= 6 months of age with significant DP (defined as head flattening requiring helmet therapy) and no major health issues will be recruited into this phase 1 descriptive pilot study&#xD;
Non-interventional: Observational</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Improved Cranial Asymmetry After Cranial Orthotic Treatment</title>
          <description>Cranial asymmetry was assessed using the Cranial Vault Asymmetry Index (CVAI). MRI's were utilized to determine CVAI. Asymmetry pre treatment was compared to post treatment to see if asymmetry improved.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Single Arm; Non-interventional</title>
          <description>A convenience sample of infants born at term gestation, that are &lt;/= 6 months of age with significant DP (defined as head flattening requiring helmet therapy) and no major health issues will be recruited into this phase 1 descriptive pilot study&#xD;
Non-interventional: Observational</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michele DeGrazia</name_or_title>
      <organization>Boston Children's Hospital</organization>
      <phone>617-919-1222</phone>
      <email>michele.degrazia@childrens.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

